Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

The Medicines Company Company Profile (NASDAQ:MDCO)

Consensus Ratings for The Medicines Company (NASDAQ:MDCO) (?)
Ratings Breakdown: 7 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Hold (Score: 2.22)
Consensus Price Target: $30.00 (16.78% upside)

Current Analysts' Coverage Summary for The Medicines Company (NASDAQ:MDCO)
Show:
DateFirmActionRatingPrice TargetDetailsShare
11/20/2014ZacksReiterated RatingNeutral -> Neutral$26.00ViewTweet This Rating  Share This Rating on StockTwits
11/20/2014Credit SuisseUpgradeNeutral -> Outperform$27.00 -> $33.00ViewTweet This Rating  Share This Rating on StockTwits
10/23/2014Citigroup Inc.Reiterated RatingNeutral$30.00 -> $27.00ViewTweet This Rating  Share This Rating on StockTwits
10/23/2014Bank of AmericaLower Price TargetBuy -> Neutral$37.00 -> $27.00ViewTweet This Rating  Share This Rating on StockTwits
4/17/2014Leerink SwannDowngradeOutperform -> Market Perform$30.00 -> $27.00ViewTweet This Rating  Share This Rating on StockTwits
4/2/2014Piper JaffrayDowngradeOverweight -> Neutral$41.00 -> $29.00ViewTweet This Rating  Share This Rating on StockTwits
3/31/2014TheStreetDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
2/13/2014RBC CapitalLower Price TargetOutperform$50.00 -> $44.00ViewTweet This Rating  Share This Rating on StockTwits
2/13/2014Jefferies GroupDowngradeBuy -> Hold$38.50 -> $27.00ViewTweet This Rating  Share This Rating on StockTwits
6/20/2013OppenheimerInitiated CoverageOutperform -> Market PerformViewTweet This Rating  Share This Rating on StockTwits
3/27/2013GuggenheimInitiated CoverageMarket Perform -> Buy$39.00ViewTweet This Rating  Share This Rating on StockTwits
2/21/2013WallachBeth CapitalBoost Price TargetBuy$30.00 -> $38.00ViewTweet This Rating  Share This Rating on StockTwits
1/3/2013Evercore ISIInitiated CoverageBuy$30.00ViewTweet This Rating  Share This Rating on StockTwits
12/20/2012JPMorgan Chase & Co.UpgradeNeutral -> Overweight$28.00 -> $28.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 11/23/2012 forward)